Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Timothy Kelliher

Neurology Beverly, MA Medical Doctor

NPI 1043314198 CMS profile 1567

152 Conant St Ste 200, Beverly, MA 01915

Open in the dashboard

General payments

$614

27 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Timothy Kelliher of Beverly, MA is reported in the CMS Open Payments database as having received $614 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 38th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $142 2
2024 General $117 5
2023 General $32 2
2022 General $104 4
2021 General $169 11
2020 General $50 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Kelliher
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Timothy Kelliher were reported at $142. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Timothy Kelliher Neurology median Middle half National median
2019 $0 $474 $118–$2,177 $163
2020 $50 $367 $82–$2,309 $114
2021 $169 $438 $104–$2,547 $132
2022 $104 $442 $103–$2,388 $149
2023 $32 $464 $119–$2,312 $160
2024 $117 $468 $119–$2,323 $164
2025 $142 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. AbbVie, Inc. $135 8 payments
  2. Lilly USA, LLC $97 1 payment
  3. Celgene Corporation $70 3 payments
  4. Kyowa Kirin, Inc. $55 4 payments
  5. Ipsen Biopharmaceuticals, Inc $48 2 payments
  6. Cala Health, Inc. $46 1 payment
  7. TG Therapeutics, Inc. $45 1 payment
  8. Adamas Pharmaceuticals, Inc. $40 2 payments
  9. Amneal Pharmaceuticals LLC $34 2 payments
  10. Teva Pharmaceuticals USA, Inc. $27 2 payments
  11. Other $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $614 27 payments
Products named General payments · program years 2020–2025
  1. UBRELVY $110 7 payments
  2. KISUNLA $97 1 payment
  3. ZEPOSIA $70 3 payments
  4. NOURIANZ $55 4 payments
  5. DYSPORT $48 2 payments
  6. CALA TRIO $46 1 payment
  7. BRIUMVI $45 1 payment
  8. BOTOX $41 2 payments
  9. GOCOVRI $40 2 payments
  10. ONGENTYS $22 1 payment
  11. Other $102 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 39 drugs

Part D claims

1,475

Median for Neurology: 833

Drug cost

$291,491

Median for Neurology: $202,670

Branded share of claims

22.9%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Avonex Pen (4 Pack) Interferon Beta-1a Brand 13 $104,200
Aimovig Autoinjector Erenumab-Aooe Brand 50 $52,046
Ubrelvy Ubrogepant Brand 40 $45,436
Glatopa Glatiramer Acetate Brand 11 $31,142
Nuedexta Dextromethorphan Hbr/Quinidine Brand 11 $19,740
Sumatriptan Succinate Generic 34 $4,218
Levetiracetam Generic 114 $4,087
Duloxetine Hcl Generic 90 $3,283
Gabapentin Generic 171 $2,480
Rivastigmine Generic 12 $2,263

The 10 drugs with the highest cost, of 39 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$289,408

Of which drugs: $106,120

Medicare patients

1,086

Average age 74

Services billed

26,159

670 women, 416 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 58%
Depression 35%
Chronic kidney disease 26%
Ischemic heart disease 25%
Osteoporosis 24%
Diabetes 23%
Cancer 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, onabotulinumtoxina, 1 unit J0585 Office 39 22,436 $105,947
Injection, methylprednisolone acetate, 1 mg J1010 Office 23 1,323 $129

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ZEPOSIA
  • Celgene Corporation $53
$53 — —
DYSPORT
  • Ipsen Biopharmaceuticals, Inc $28
$28 — —
ONGENTYS
  • Amneal Pharmaceuticals LLC $22
$22 — —
UBRELVY
  • AbbVie, Inc. $7
$7 40 —
BOTOX
  • AbbVie, Inc. $7
$7 — 22,436

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record